NCT03956979 - A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

March 7, 2024

Study Completion Date

March 21, 2024

Conditions

Dyskinesias

Interventions

DRUG

JM-010 group A

JM-010 fixed combination drug (Group A) + Placebo 2

DRUG

JM-010 group B

JM-010 fixed combination drug (Group B) + Placebo 1

DRUG

Placebos

Placebo 1 + Placebo 2

Trial Locations (5)

Contera Investigational site_FR, Toulouse

Contera Investigational site_DE, Rostock

Contera Investigational site_IT, Roma

Contera Investigational site_KOR, Seoul

Contera Investigational site_ES, Madrid